Formamide

Formamide

SCHEMBL6754148

NC=O.Nc1cccc2c1CCCC2=O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.47
BRD4 O60885 6/20 0.44
CYP2A6 P11509 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.37
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR1A P08908 1/20 0.35
ADRB3 P13945 1/20 0.35
TSHR P16473 1/20 0.35
SLC6A4 P31645 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
TYMS P04818 1/20 0.35
PTPRC P08575 1/20 0.34
ADORA2A P29274 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768935 0.93 PARP1 (0.53) PARP1BRD4CYP2A6MAOAMAOB
Urea SCHEMBL6754151 0.86 BRD4 (0.48) PARP1BRD4CYP2A6MAOAMAOB
SCHEMBL2480404 0.81 PARP1 (0.56) PARP1BRD4CYP2A6MAOAMAOB
SCHEMBL7555603 0.75 BRD4 (0.42) PARP1BRD4ADRB2ADRB1ADRB3
SCHEMBL11741399 0.75 CYP2A6 (0.46) BRD4CYP2A6MAOAMAOBMRGPRX4
SCHEMBL1151194 0.72 PARP1 (0.55) PARP1BRD4CYP2A6MAOAMAOB
SCHEMBL5540741 0.72 MAOA (0.50) BRD4CYP2A6MAOAMAOBMRGPRX4
SCHEMBL29501042 0.72 PARP1 (0.55) PARP1BRD4CYP2A6MAOAMAOB
SCHEMBL8502152 0.71 PARP1 (0.48) PARP1BRD4MAOATSHRPTPRC
SCHEMBL22479791 0.71 MAOA (0.48) BRD4CYP2A6MAOAMAOBMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6706924-B2 INCLUDES A STEP IN WHICH ORTHO-NITROTOLUENE IS REACTED WITH ONE OR MORE ACRYLIC ACID DERIVATIVES SUCH AS ACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 2004-03-16 US claimed
US-20020103401-A1 Process for the production of 1,5-naphthalenediamine BAYER AKTIENGESELLSCHAFT (DE) 2002-08-01 US claimed
US-6706924-B2 INCLUDES A STEP IN WHICH ORTHO-NITROTOLUENE IS REACTED WITH ONE OR MORE ACRYLIC ACID DERIVATIVES SUCH AS ACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 2004-03-16 US disclosed
US-20020103401-A1 Process for the production of 1,5-naphthalenediamine BAYER AKTIENGESELLSCHAFT (DE) 2002-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103401-A1 Process for the production of 1,5-naphthalenediamine BBOX1, CYP4B1, NAT1 PARP1 1388/4885BRD4 165/4885CYP2A6 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.